PureTech Health
PRTC
PRTC was delisted on the 20th of May, 2026.
5 hedge funds and large institutions have $1.87M invested in PureTech Health in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
216% more capital invested
Capital invested by funds: $593K → $1.87M (+$1.28M)
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
25% more funds holding
Funds holding: 4 → 5 (+1)
0.14% more ownership
Funds ownership: 0.01% → 0.16% (+0.14%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| 1 |
BHIA
Birch Hill Investment Advisors
Boston,
Massachusetts
|
+$6.33M |
| 2 |
Millennium Management
New York
|
+$948K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$26.3K |
Top Sellers
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$61.8K |
| 2 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$18.6K |
PRTC Hedge Fund Activity: Q4 2024 in Review
5 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in PureTech Health (PRTC) for Q4 2024, worth a combined $1.87M — up 216% from $593K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PRTC positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Birch Hill Investment Advisors, opening a new position worth an estimated $6.33M. The largest seller was ADAR1 Capital Management, exiting entirely with an estimated $61.8K sold.
- 5 institutional investors held PureTech Health (PRTC) as of Q4 2024, up from 4 in Q3 2024.
- Funds reported $1.87M of PureTech Health stock for Q4 2024, up 216% quarter-over-quarter.
- 2 funds opened new PureTech Health positions in Q4 2024 and 1 closed out, a net change of +1 holder.
- The largest PureTech Health buyer in Q4 2024 was Birch Hill Investment Advisors, an estimated $6.33M added.
- The largest PureTech Health seller in Q4 2024 was ADAR1 Capital Management, an estimated $61.8K sold.
Based on aggregated 13F filings for Q4 2024.